SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 6

History of Contrast Media: Celebrating the Centenary of the Use of Lipiodol® in Radiology

Bruno BONNEMAIN
Pages
626–630
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, the landscape has changed in recent years in radiology, with imaging taking the lead in the current diagnostic scheme.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:On the occasion of the centenary of the first use of an iodinated contrast agent (Lipiodol®) in 1921, this review traces the history of contrast agents that have closely accompanied the innovation of radiology equipment.
📊
Key Findings & Data:Other water-soluble products then appeared with a radical change in 1953 with the marketing of diatrizoate.
💡
Conclusion & Impact:Thus, the landscape has changed in recent years in radiology, with imaging taking the lead in the current diagnostic scheme.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

On the occasion of the centenary of the first use of an iodinated contrast agent (Lipiodol®) in 1921, this review traces the history of contrast agents that have closely accompanied the innovation of radiology equipment. Lipiodol is an iodinated oil that has made it possible to highlight the interest of the visualization of closed structures of the body (e.g., lung, subarachnoid space, bladder, and joints) and blood and lymphatic vessels. Other water-soluble products then appeared with a radical change in 1953 with the marketing of diatrizoate. The appearance of computed tomography scanners was concomitant with that of low osmolality iodinated contrast products. The arrival of magnetic resonance imaging was quickly followed by gadolinium complexes and then superparamagnetic particles based on iron oxide particles. Thus, the landscape has changed in recent years in radiology, with imaging taking the lead in the current diagnostic scheme.

🔖

Cite This Article

BONNEMAIN, B. (2022). History of Contrast Media: Celebrating the Centenary of the Use of Lipiodol® in Radiology. Erciyes Medical Journal, Cilt: 43 - Sayı: 6, 626–630. https://ajindex.com/articles/502185

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Moreau JF. Produits de contraste radiologiques. J Radiol 1994; 75(10): 489–91
  2. Thomas AM, Banerjee AK. The history of radiology. Oxford: Oxford University Press; 2013
  3. Pollack HM. History of iodinated contrast media. In: Trends in Contrast Media. Berlin: Springer Verlag; 1999. p. 3–19
  4. Sicard JA, Forestier J. Diagnostic et Thérapeutique Par le Lipiodol: Clinique et Radiologie. Paris: Masson; 1928
  5. Bonnemain B, Guerbet M. The history of Lipiodol (1901-1994) or How a medication may evolve with the times. Rev Hist Pharm (Paris) 1995; 42(305): 159–70
  6. Osborne ED, Sutherland CG, Scholl AJ Jr., Rowntree LG. Landmark article Feb 10, 1923: Roentgenography of urinary tract during excretion of sodium iodid. By Earl D. Osborne, Charles G. Sutherland, Albert J. Scholl, Jr. and Leonard G. Rowntree. JAMA 1983; 250(20): 2848–53. 7. von Lichtenberg DA. Principles and new advances in excretion urography. Br J Urol 1931; 3(2): 119–65
  7. Bonnemain B, Guerbet M. The discovery of Tenebryl, the first French uro-angiographic iodized hydrosoluble product. Rev Hist Pharm (Paris) 1995; 42(306): 279–84
  8. Buschur M, Aspelin P. Contrast media: History and chemical properties. Interv Cardiol Clin 2014; 3(3): 333–9
  9. Feld R, Kurtz AB, Zeman RK. Imaging the gallbladder: A historical perspective. Am J Roentgenol 1991; 156(4): 737–40
  10. Stevenson JJ. Telepaque: A new contrast material for cholecystography. Br J Radiol 1952; 25(298): 531–4
  11. Sovak M. Contrast media: A journey almost sentimental. Invest Radiol 1994; 29(Suppl 1): S4–14
  12. Wilmot A, Mehta N, Jha S. The adoption of low-osmolar contrast agents in the United States: Historical analysis of health policy and clinical practice. Am J Roentgenol 2012; 199(5): 1049–53
  13. McClennan BL, Stolberg HO. Intravascular contrast media. Ionic versus nonionic: Current status. Radiol Clin North Am 1991; 29(3): 437–54
  14. Moreau JF, Hélénon O, Souissi M, Chabriais J. Iodinated radiological contrast agents in 1992. J Radiol 1992; 73(6-7): 357–60
  15. Gardeur D, Lautrou J, Millard JC, Berger N, Metzger J. Pharmacokinetics of contrast media: Experimental results in dog and man with CT implications. J Comput Assist Tomogr 1980; 4(2): 178–85
  16. Kormano M, Dean PB. Extravascular contrast material: The major component of contrast enhancement. Radiology 1976; 121(2): 379–82
  17. Caillé JM. Conditions d’utilisation des produits de contraste en neuroradiologie. J Radiol 1977; 58: 237–8
  18. Parvez Z, Moncada R, Sovak M. Co